• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Carbon Health acquires Steady Health and its diabetes platform

June 4, 2021 By Sean Whooley

Carbon HealthCarbon Health announced today that it acquired Steady Health and its platform for using continuous glucose monitoring to personalize diabetes care.

San Francisco–based Carbon Health said in a news release that the acquisition accelerates its rollout of a new primary care model designed to integrate its clinic footprint with virtual and hardware-enabled capabilities to create high-quality, accessible healthcare.

“From day one, our mission has been to increase the accessibility of high-quality care, which means continuing to increase access points and improve communication between patients and healthcare providers,” Carbon Health co-founder & CEO Eren Bali said in the release. “Devices like CGMs create an opportunity to connect a patient with their provider in a way not possible before, to drive better outcomes. Diabetes is one of the most pervasive and expensive health conditions in the U.S., and we are excited to partner with Henrik Berggren and his team at Steady Health to help elevate the management of diabetes.

“The Steady Health care platform is also one that Carbon intends to leverage to expand into the management of other chronic conditions in the future.”

Steady Health’s diabetes platform connects patients with experts and uses data from CGM devices to provide personalized insights and improve the management of diabetes.

“With top endocrinologists and our care platform, we’re delivering unmatched medical care through a dramatically improved connected patient-provider experience,” Steady Health founder and CEO Henrik Berggren said. “Becoming part of Carbon Health will enable us to provide end-to-end care for our patients, including in-person visits at a Carbon clinic when needed. We’re super excited to carry on our mission of empowering people with diabetes to live the life they want.”

In addition to the announcement of the acquisition, Carbon said it appointed former Apple Health executive Myoung Cha as its chief strategy officer and former Honor president Nita Sommers as its chief growth officer.

Cha’s responsibilities center around growing the company’s device-enabled home care options. At the same time, Sommers will expand Carbon Health’s services into areas including mental health and pediatrics while also building out its value-based offerings for employers and payers.

“Myoung and Nita are two incredible powerhouses with deep, strategic healthcare experience that will enable Carbon to get even closer to our vision of healthcare accessibility,” Bali said. “As we continue to expand our services and omnichannel care model — with a goal of expanding to 1,500 clinics across the U.S. by the end of 2025 — home- and value-based care offerings will be critical components that will enable patients to get everything they need for their health where and when they need it most.”

Filed Under: Business/Financial News, Diabetes, Featured, Mergers & Acquisitions, Patient Monitoring Tagged With: Carbon Health, Personnel, Personnel Moves

IN CASE YOU MISSED IT

  • Medtronic moves to divest final stake in MiniMed
  • Dexcom adds former Stryker CFO to board
  • MiniMed wins CE mark for next-gen insulin pump, ups revenue guidance
  • Abbott wins FDA authorization for dual glucose-ketone sensor
  • FDA clears Roche’s Alzheimer’s blood test for rule-in and rule-out assessment 

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS